{
  "ticker": "INCY",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 17,
  "transactions": [
    {
      "id": 307842,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Denton Sheila A.",
      "reporting_owner_cik": "0001995298",
      "reporting_owner_position": "EVP & General Counsel",
      "transaction_date": "2025-02-26",
      "transaction_shares": "9574",
      "transaction_price": "58.06",
      "transaction_type": "M",
      "shares_after_transaction": "39917"
    },
    {
      "id": 307804,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Heeson Lee",
      "reporting_owner_cik": "0002039219",
      "reporting_owner_position": "EVP, Head of Incyte Intl",
      "transaction_date": "2025-01-31",
      "transaction_shares": "6331",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32778"
    },
    {
      "id": 307816,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Morrissey Michael James",
      "reporting_owner_cik": "0001780915",
      "reporting_owner_position": "EVP, Head of Tech. Operations",
      "transaction_date": "2025-01-31",
      "transaction_shares": "10552",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81515"
    },
    {
      "id": 266204,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Morrissey Michael James",
      "reporting_owner_cik": "0001780915",
      "reporting_owner_position": "EVP, Head of Tech. Operations",
      "transaction_date": "2025-01-21",
      "transaction_shares": "429",
      "transaction_price": "73.47",
      "transaction_type": "F",
      "shares_after_transaction": "70963"
    },
    {
      "id": 266213,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stein Steven H",
      "reporting_owner_cik": "0001673776",
      "reporting_owner_position": "EVP & Chief Medical Officer",
      "transaction_date": "2025-01-21",
      "transaction_shares": "12352",
      "transaction_price": "72.69",
      "transaction_type": "S",
      "shares_after_transaction": "66967"
    },
    {
      "id": 307834,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Morrissey Michael James",
      "reporting_owner_cik": "0001780915",
      "reporting_owner_position": "EVP, Head of Tech. Operations",
      "transaction_date": "2025-01-21",
      "transaction_shares": "429",
      "transaction_price": "73.47",
      "transaction_type": "F",
      "shares_after_transaction": "70963"
    },
    {
      "id": 307844,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stein Steven H",
      "reporting_owner_cik": "0001673776",
      "reporting_owner_position": "EVP & Chief Medical Officer",
      "transaction_date": "2025-01-21",
      "transaction_shares": "12352",
      "transaction_price": "72.69",
      "transaction_type": "S",
      "shares_after_transaction": "66967"
    },
    {
      "id": 266188,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stein Steven H",
      "reporting_owner_cik": "0001673776",
      "reporting_owner_position": "EVP & Chief Medical Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "10692",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "79319"
    },
    {
      "id": 266190,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Morrissey Michael James",
      "reporting_owner_cik": "0001780915",
      "reporting_owner_position": "EVP, Head of Tech. Operations",
      "transaction_date": "2025-01-15",
      "transaction_shares": "908",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "71392"
    },
    {
      "id": 266215,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Flannelly Barry P",
      "reporting_owner_cik": "0001615842",
      "reporting_owner_position": "EVP & General Manager US",
      "transaction_date": "2025-01-15",
      "transaction_shares": "3158",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "53374"
    },
    {
      "id": 266232,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stamoulis Christiana",
      "reporting_owner_cik": "0001502917",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "3672",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "91525"
    },
    {
      "id": 307818,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stein Steven H",
      "reporting_owner_cik": "0001673776",
      "reporting_owner_position": "EVP & Chief Medical Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "10692",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "79319"
    },
    {
      "id": 307820,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Morrissey Michael James",
      "reporting_owner_cik": "0001780915",
      "reporting_owner_position": "EVP, Head of Tech. Operations",
      "transaction_date": "2025-01-15",
      "transaction_shares": "908",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "71392"
    },
    {
      "id": 307846,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Flannelly Barry P",
      "reporting_owner_cik": "0001615842",
      "reporting_owner_position": "EVP & General Manager US",
      "transaction_date": "2025-01-15",
      "transaction_shares": "3158",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "53374"
    },
    {
      "id": 307863,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Stamoulis Christiana",
      "reporting_owner_cik": "0001502917",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "3672",
      "transaction_price": "72.46",
      "transaction_type": "F",
      "shares_after_transaction": "91525"
    },
    {
      "id": 266180,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Issa Mohamed Khairie",
      "reporting_owner_cik": "0002050035",
      "reporting_owner_position": "EVP, Head of US Oncology",
      "transaction_date": "2025-01-06",
      "transaction_shares": "48671",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "48671"
    },
    {
      "id": 307809,
      "issuer_name": "INCYTE CORP",
      "reporting_owner": "Issa Mohamed Khairie",
      "reporting_owner_cik": "0002050035",
      "reporting_owner_position": "EVP, Head of US Oncology",
      "transaction_date": "2025-01-06",
      "transaction_shares": "48671",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "48671"
    }
  ]
}